Nanomaterials in the Management of Gram-Negative Bacterial Infections

被引:26
|
作者
Barani, Mahmood [1 ]
Zeeshan, Mahira [2 ]
Kalantar-Neyestanaki, Davood [1 ,3 ]
Farooq, Muhammad Asim [4 ]
Rahdar, Abbas [5 ]
Jha, Niraj Kumar [6 ]
Sargazi, Saman [7 ]
Gupta, Piyush Kumar [8 ]
Thakur, Vijay Kumar [9 ,10 ,11 ]
机构
[1] Kerman Univ Med Sci, Med Mycol & Bacteriol Res Ctr, Kerman 7616913555, Iran
[2] Quaid I Azam Univ, Fac Biol Sci, Dept Pharm, Islamabad 45320, Pakistan
[3] Kerman Univ Med Sci, Afzalipour Fac Med, Dept Med Microbiol Bacteriol & Virol, Kerman 7616913555, Iran
[4] Univ Lahore, Fac Pharm, Dept Pharmaceut, Lahore 54000, Pakistan
[5] Univ Zabol, Dept Phys, Zabol 9861335856, Iran
[6] Sharda Univ, Sch Engn & Technol, Dept Biotechnol, Greater Noida 201310, India
[7] Zahedan Univ Med Sci, Res Inst Cellular & Mol Sci Infect Dis, Cellular & Mol Res Ctr, Zahedan 9816743463, Iran
[8] Sharda Univ, Sch Basic Sci & Res, Dept Life Sci, Greater Noida 201310, India
[9] Biorefining & Adv Mat Res Ctr, SRUC, Edinburgh EH9 3JG, Midlothian, Scotland
[10] Shiv Nadar Univ, Sch Engn, Dept Mech Engn, Greater Noida 201314, India
[11] Univ Petr & Energy Studies UPES, Sch Engn, Dehra Dun 248007, Uttarakhand, India
关键词
Escherichia coli; nanotechnology; infection; diagnosis; treatment; ESCHERICHIA-COLI; ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; SILVER NANOPARTICLES; PATHOGENIC BACTERIA; GOLD NANOPARTICLES; BIOSENSOR; STRATEGIES; SENSITIVITY; DIAGNOSIS;
D O I
10.3390/nano11102535
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The exploration of multiplexed bacterial virulence factors is a major problem in the early stages of Escherichia coli infection therapy. Traditional methods for detecting Escherichia coli (E. coli), such as serological experiments, immunoassays, polymerase chain reaction, and isothermal microcalorimetry have some drawbacks. As a result, detecting E. coli in a timely, cost-effective, and sensitive manner is critical for various areas of human safety and health. Intelligent devices based on nanotechnology are paving the way for fast and early detection of E. coli at the point of care. Due to their specific optical, magnetic, and electrical capabilities, nanostructures can play an important role in bacterial sensors. Another one of the applications involved use of nanomaterials in fighting microbial infections, including E. coli mediated infections. Various types of nanomaterials, either used directly as an antibacterial agent such as metallic nanoparticles (NPs) (silver, gold, zinc, etc.), or as a nanocarrier to deliver and target the antibiotic to the E. coli and its infected area. Among different types, polymeric NPs, lipidic nanocarriers, metallic nanocarriers, nanomicelles, nanoemulsion/ nanosuspension, dendrimers, graphene, etc. proved to be effective vehicles to deliver the drug in a controlled fashion at the targeted site with lower off-site drug leakage and side effects.
引用
收藏
页数:26
相关论文
共 50 条
  • [21] Management of nonfermenting gram-negative infections: a critique of the guidelines
    Bassetti, Matteo
    Vena, Antonio
    Giacobbe, Daniele Roberto
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2023, 36 (06) : 609 - 614
  • [22] An update on endotoxin neutralization strategies in Gram-negative bacterial infections
    Brandenburg, Klaus
    Schromm, Andra B.
    Weindl, Guenther
    Heinbockel, Lena
    Correa, Wilmar
    Mauss, Karl
    Martinez de Tejada, Guillermo
    Garidel, Patrick
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2021, 19 (04) : 495 - 517
  • [23] Correction to: Cefiderocol: A Review in Serious Gram-Negative Bacterial Infections
    Yahiya Y. Syed
    [J]. Drugs, 2021, 81 : 2167 - 2167
  • [24] Risk factors for Gram-negative bacterial infections in febrile neutropenia
    Cordonnier, Catherine
    Herbrecht, Raoul
    Buzyn, Agnes
    Leverger, Guy
    Leclercq, Roland
    Nitenberg, Gerard
    Bastuji-Garin, Sylvie
    [J]. HAEMATOLOGICA, 2005, 90 (08) : 1102 - 1109
  • [25] REDUCING MORTALITY FROM GRAM-NEGATIVE BACTERIAL-INFECTIONS
    PHAIR, JP
    BASSARIS, HP
    WILLIAMS, JE
    [J]. GERIATRICS, 1982, 37 (09) : 47 - 50
  • [26] Imipenem/Cilastatin/Relebactam: A Review in Gram-Negative Bacterial Infections
    Young-A. Heo
    [J]. Drugs, 2021, 81 : 377 - 388
  • [27] Combating multidrug-resistant Gram-negative bacterial infections
    Xu, Ze-Qi
    Flavin, Michael T.
    Flavin, John
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (02) : 163 - 182
  • [28] Carbapenem-Resistant Gram-Negative Bacterial Infections in Children
    Aguilera-Alonso, David
    Escosa-Garcia, Luis
    Saavedra-Lozano, Jesus
    Cercenado, Emilia
    Baquero-Artigao, Fernando
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (03)
  • [29] Unrealized targets in the discovery of antibiotics for Gram-negative bacterial infections
    Theuretzbacher, Ursula
    Blasco, Benjamin
    Duffey, Maelle
    Piddock, Laura J. V.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (12) : 957 - 975
  • [30] AZTREONAM IN THE TREATMENT OF GRAM-NEGATIVE MENINGITIS AND OTHER GRAM-NEGATIVE INFECTIONS
    FERIS, J
    MOLEDINA, N
    RODRIGUEZ, WJ
    KHAN, WN
    PUIG, J
    WIEDERMANN, BL
    AHMAD, S
    [J]. CHEMOTHERAPY, 1989, 35 : 31 - 38